CBT
CABOT CORP
NYSE · Basic Materials · Chemicals - Specialty · US
$75.61
+5.01%Next report
Analyst consensus
- Next report date
- Feb 2, 2027
- EPS estimate
- $1.58
- Revenue estimate
- $859.5M
Latest reported
- Last report date
- Nov 3, 2026
- EPS actual
- $1.61
- EPS estimate
- $1.55
- Revenue actual
- $1.0B
- Revenue estimate
- $927.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +6.0%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Sell
- Price target
- $82
- PT range
- $78 – $86
- Analysts
- 2
0 Buy1 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 3, 2026 | $1.55 | $1.61 | Beat 3.87% | $1.0B |
| Aug 4, 2026 | $1.65 | $1.67 | Beat 1.21% | $982.0M |
| May 6, 2026 | $1.47 | $1.61 | Beat 9.52% | $904.0M |
| Feb 3, 2026 | $1.40 | $1.53 | Beat 9.29% | $849.0M |
| Feb 3, 2025 | $1.74 | $1.76 | Beat 1.15% | $955.0M |
| Feb 9, 2023 | $0.97 | $0.98 | Beat 1.03% | $965.0M |
| May 2, 2022 | $1.42 | $1.69 | Beat 19.01% | $1.1B |
| Jan 31, 2022 | $1.06 | $1.29 | Beat 21.70% | $968.0M |
| May 3, 2021 | $0.97 | $1.38 | Beat 42.27% | $842.0M |
| Feb 1, 2021 | $0.88 | $1.18 | Beat 34.09% | $746.0M |
| Nov 23, 2020 | $0.58 | $0.68 | Beat 17.24% | $659.0M |
| Aug 6, 2020 | -$0.02 | -$0.07 | Miss -319.92% | $518.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 2, 2027